MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 162 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $15,485,000 | +29.7% | 295,070 | -17.8% | 0.01% | +30.0% |
Q2 2020 | $11,939,000 | +12.5% | 358,840 | -8.0% | 0.01% | 0.0% |
Q1 2020 | $10,610,000 | -80.4% | 390,080 | -85.8% | 0.01% | -74.4% |
Q4 2019 | $54,246,000 | +52.2% | 2,749,400 | 0.0% | 0.04% | +39.3% |
Q3 2019 | $35,632,000 | -7.3% | 2,749,400 | -10.9% | 0.03% | 0.0% |
Q2 2019 | $38,419,000 | -14.2% | 3,085,900 | +0.2% | 0.03% | -15.2% |
Q1 2019 | $44,762,000 | +32.6% | 3,080,660 | +0.8% | 0.03% | +22.2% |
Q4 2018 | $33,746,000 | -55.6% | 3,056,695 | +5.8% | 0.03% | -47.1% |
Q3 2018 | $75,957,000 | +28.6% | 2,888,100 | 0.0% | 0.05% | +15.9% |
Q2 2018 | $59,062,000 | +12.7% | 2,888,100 | 0.0% | 0.04% | +12.8% |
Q1 2018 | $52,419,000 | +31.0% | 2,888,100 | +0.7% | 0.04% | +25.8% |
Q4 2017 | $40,021,000 | -23.8% | 2,868,900 | +1.1% | 0.03% | -27.9% |
Q3 2017 | $52,520,000 | +9.4% | 2,838,900 | -0.0% | 0.04% | +4.9% |
Q2 2017 | $47,994,000 | +31.2% | 2,839,900 | +3.6% | 0.04% | +24.2% |
Q1 2017 | $36,578,000 | -11.3% | 2,739,900 | 0.0% | 0.03% | -19.5% |
Q4 2016 | $41,235,000 | +28.7% | 2,739,900 | 0.0% | 0.04% | +28.1% |
Q3 2016 | $32,029,000 | +8.3% | 2,739,900 | +0.0% | 0.03% | +3.2% |
Q2 2016 | $29,580,000 | +16.9% | 2,738,900 | 0.0% | 0.03% | +19.2% |
Q1 2016 | $25,307,000 | -37.7% | 2,738,900 | 0.0% | 0.03% | -38.1% |
Q4 2015 | $40,645,000 | -8.3% | 2,738,900 | +1.4% | 0.04% | -14.3% |
Q3 2015 | $44,322,000 | -28.1% | 2,700,900 | 0.0% | 0.05% | -19.7% |
Q2 2015 | $61,608,000 | +50.4% | 2,700,900 | +0.2% | 0.06% | +52.5% |
Q1 2015 | $40,966,000 | +27.4% | 2,695,100 | +0.9% | 0.04% | +21.2% |
Q4 2014 | $32,154,000 | +6.2% | 2,670,600 | 0.0% | 0.03% | +3.1% |
Q3 2014 | $30,285,000 | -6.1% | 2,670,600 | 0.0% | 0.03% | -8.6% |
Q2 2014 | $32,261,000 | +28.2% | 2,670,600 | +23.7% | 0.04% | +25.0% |
Q1 2014 | $25,157,000 | -5.5% | 2,159,414 | +43.5% | 0.03% | -12.5% |
Q4 2013 | $26,608,000 | +22.9% | 1,505,000 | 0.0% | 0.03% | +14.3% |
Q3 2013 | $21,657,000 | +2.8% | 1,505,000 | +7.6% | 0.03% | -6.7% |
Q2 2013 | $21,069,000 | – | 1,399,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 159,197 | $5,296,000 | 4.06% |
Ghost Tree Capital, LLC | 385,000 | $12,809,000 | 3.38% |
Copernicus Capital Management, LLC | 88,000 | $2,928,000 | 3.21% |
Palo Alto Investors LP | 1,479,524 | $49,224,000 | 2.96% |
Redmile Group, LLC | 4,705,308 | $156,546,000 | 2.89% |
Avidity Partners Management LP | 1,150,000 | $38,261,000 | 2.45% |
RA Capital Management | 2,531,445 | $84,221,000 | 1.64% |
MAVERICK CAPITAL LTD | 2,314,756 | $77,012,000 | 1.62% |
Integral Health Asset Management, LLC | 150,000 | $4,991,000 | 1.50% |
PFM Health Sciences, LP | 579,994 | $19,296,000 | 1.00% |